SCHEMBL7112682

SCHEMBL7112682

CCCCCc1ccc(N(C(=O)OC(C)(C)C)[N+](=O)[O-])cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.41
ALDH1A1 P00352 2/20 0.41
FAAH O00519 1/20 0.40
THRB P10828 3/20 0.39
RARB P10826 5/20 0.39
HAO1 Q9UJM8 1/20 0.39
TNNC1 P63316 5/20 0.38
THRA P10827 2/20 0.38
SGPL1 O95470 1/20 0.38
S1PR4 O95977 1/20 0.38
S1PR1 P21453 1/20 0.38
GPR183 P32249 1/20 0.38
CERS2 Q96G23 1/20 0.38
S1PR3 Q99500 1/20 0.38
S1PR5 Q9H228 1/20 0.38
MEN1 O00255 1/20 0.38
RARA P10276 1/20 0.38
MAPT P10636 1/20 0.38
MTOR P42345 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL177445 0.79 THRA (0.47) ALDH1A1FAAHTHRBRARBTHRA
SCHEMBL6880352 0.77 MT-CO2 (0.46) ALDH1A1MEN1MAPTKMT2A
SCHEMBL5755875 0.75 HPGD (0.44) ALDH1A1FAAHTHRBRARBTHRA
SCHEMBL28781248 0.72 THRA (0.50) ALDH1A1FAAHTHRBRARBTHRA
SCHEMBL8293510 0.71 RARB (0.55) ALDH1A1FAAHTHRBRARBTHRA
SCHEMBL15807642 0.71 KCNH2 (0.47) KCNH2THRBMEN1MAPTKMT2A
SCHEMBL8697616 0.71 S1PR2 (0.42) ALDH1A1FAAHTHRBRARBTHRA
SCHEMBL2133261 0.70 GABRA5 (0.39)
SCHEMBL6878251 0.69 RAB9A (0.39) ALDH1A1THRBS1PR3MEN1MAPT
SCHEMBL978403 0.69 GPR119 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474416-A1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-10 EP disclosed
WO-2003066623-A1 DIHYDROBENZODIAZEPIN-2-ONE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 WO disclosed